Patrys Ltd's (ASX:PAB) shares have continued to rally during the trading day, and are now up 200% at $0.012, with over 84 million shares changing hands.
That means Patrys isn't just one of the most active today, but also the best performer.
The market attention followed positive pre-clinical data for its lead drug candidate PAT-DX1, a novel first-in-class drug candidate being developed to treat a range of different cancers.
Studies in multiple pre-clinical models of cancer have demonstrated the ability of Patrys’ proprietary humanized antibody, PAT-DX1 to be taken-up and to kill cancer cells.
This confirms the successful humanization and de-immunization of 3E10-derived antibody fragments with conserved structural properties and enhanced in vitro activity.
|Pancontinental Oil & Gas NL||PCL||$0.004||33.33%||177,014,965|
|Magnum Gas & Power||MPE||$0.002||0%||64,351,525|
|Lynas Corporation Ltd||LYC||$0.195||0%||60,070,170|
|Valor Resources Ltd||VAL||$0.032||18.52%||41,413,610|
|Pure Minerals Ltd||PM1||$0.024||14.29%||24,448,949|
|Pacifico Minerals Ltd||PMY||$0.007||16.67%||24,322,930|
|Clancy Exploration Ltd||CLY||$0.003||50%||19,438,150|
|ResApp Health Ltd||RAP||$0.076||-10.59%||15,150,421|